Cas 1125744-79-7,4-bromo-2-chloro-N-(2,3-difluorophenyl)-3-oxobutanamide

1125744-79-7

Post Buying Request

Basic information

Product Name: 4-bromo-2-chloro-N-(2,3-difluorophenyl)-3-oxobutanamide
Synonyms: 4-bromo-2-chloro-N-(2,3-difluorophenyl)-3-oxobutanamide
CAS NO:1125744-79-7
Molecular Formula:
Molecular Weight: 326.525
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-bromo-2-chloro-N-(2,3-difluorophenyl)-3-oxobutanamide(CAS DataBase Reference)
NIST Chemistry Reference: 4-bromo-2-chloro-N-(2,3-difluorophenyl)-3-oxobutanamide(1125744-79-7)
EPA Substance Registry System: 4-bromo-2-chloro-N-(2,3-difluorophenyl)-3-oxobutanamide(1125744-79-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1125744-79-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1125744-79-7 Suppliers

Recommended suppliers

1125744-79-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1125744-79-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,2,5,7,4 and 4 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1125744-79:
(9*1)+(8*1)+(7*2)+(6*5)+(5*7)+(4*4)+(3*4)+(2*7)+(1*9)=147
147 % 10 = 7
So 1125744-79-7 is a valid CAS Registry Number.

1125744-79-7Upstream product

953071-01-7 4-bromo-N-(2,3-difluorophenyl)-3-oxobutanamide

1125744-79-7Downstream Products

1125744-79-7Relevant academic research and scientific papers

HETEROBICYCLIC-SUBSTITUTED QUINOLONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS

-

Page/Page column 46, (2009/04/25)

Novel Quinolone derivatives and pharmaceutical compositions, certain of which have been found to inhibit inducible NOS synthase have been discovered, together with methods of synthesizing and using the compounds including methods for the treatment of iNOS-mediated diseases in a patient by administering the compounds.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1125744-79-7